Poniard Pharmaceuticals, Inc.
PARD · OTC
9/30/2011 | 6/30/2011 | 3/31/2011 | 12/31/2010 | |
|---|---|---|---|---|
| Market Cap | $7,492 | $13,696 | $22,663 | $26,246 |
| - Cash | $1,984 | $3,692 | $5,472 | $1,284 |
| + Debt | $1,640 | $1,618 | $1,596 | $1,574 |
| Enterprise Value | $7,148 | $11,622 | $18,787 | $26,536 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$3,437 | -$3,521 | -$2,909 | -$4,391 |
| % Margin | – | – | – | – |
| Net Income | -$3,771 | -$3,858 | -$3,246 | -$5,167 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.4 | -2.8 | -2.4 | -4.09 |
| % Growth | 14.3% | -16.7% | 41.3% | – |
| Operating Cash Flow | -$1,708 | -$1,682 | -$2,021 | -$5,046 |
| Capital Expenditures | $0 | -$2 | -$7 | $0 |
| Free Cash Flow | -$1,708 | -$1,684 | -$2,028 | -$5,046 |